NCT07808398Not yet recruiting
Comparing Glycemic Outcomes of Carbohydrate Counting vs. Fixed Mealtime Insulin Dosing in Hospitalized Patients With Hyperglycemia
Comparing Glycemic Outcomes of Carbohydrate Counting vs. Fixed Mealtime Insulin Dosing in Hospitalized Patients With Hyperglycemia: an EHR-embedded Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 8 Sept 2026
Brief summary (registry, in English)
The study compares two current practices for calculating insulin dose for admitted patients: flexible fixed mealtime dosing based on percent of meal eaten and carbohydrate counting based on amount of carbohydrates eaten.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- First submitted
- 2 Sept 2026
- Start date
- 1 Oct 2026
- Primary completion date
- 30 Apr 2027
- Lead sponsor
- Mayo Clinic
- Diseases
- Type 2 diabetes
- NCT number
- NCT07808398
What you commit to
- Study type: Interventional
- Planned participants: 500
- From 1 Oct 2026 to the primary completion date, 30 Apr 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of type 1 DM
- History of total pancreatectomy
- Critical illness requiring ICU admission at time of recruitment.
Other
- Use of pre-admission CC for prandial insulin administration
- Admission to psychiatry services
- Pregnancy
- All forms of enteral/tube feeding or parenteral nutrition at recruitment
- Observation status at time of recruitment
Who the study is looking for
- Adults ≥18 years
- Admitted to non-ICU units
- Require scheduled prandial insulin as part of basal-bolus insulin therapy with CC.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.